Skip to main
G

Genpact (G) Stock Forecast & Price Target

Genpact (G) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 0%
Hold 71%
Sell 0%
Strong Sell 0%

Bulls say

Genpact is well-positioned to thrive in today's increasingly digital and data-driven economy, with a strong focus on advanced technology solutions such as AI and data engineering. The company's solid 1Q results and promising pipeline for ATs indicate continued growth potential, and its attractive valuation with a P/E ratio of ~7x FY27 EPS makes it an appealing investment opportunity. Additionally, Genpact's balanced approach to returning capital to shareholders through buybacks and dividends provides added value for investors.

Bears say

Genpact is a company that has consistently delivered solid financial results in the past, thanks to its advanced technology solutions and strong demand for its services. However, the company's recent performance has shown some weakness in terms of attrition rates and revenue growth, especially in its consumer and healthcare segment, which is facing challenges due to geopolitical risks and tariffs. Additionally, the company's valuation is currently trading at a discount compared to its peers, indicating a potentially undervalued stock. Considering these factors, the outlook for Genpact's stock in the near future is cautious, although it could potentially see significant upside if there is an improvement in the economic environment and a rebound in business confidence, leading to increased demand for its services.

Genpact (G) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 0% recommend Buy, 71% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Genpact and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Genpact (G) Forecast

Analysts have given Genpact (G) a Buy based on their latest research and market trends.

According to 7 analysts, Genpact (G) has a Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $40.14, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $40.14, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Genpact (G)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.